Exhibit 10.3

 

AGREEMENT REGARDING STOCK SALE

 

This Agreement Regarding Stock Sale (this “Agreement”), is made and entered into
as of December 17, 2018 (the “Effective Date”) by and between Repro-Med Systems,
Inc. d/b/a RMS Medical Products, a New York corporation (the “Company”), and Dr.
Paul Mark Baker, a New York resident (the “Seller”).

 

WHEREAS, the Seller is currently serving as a director of the Company and owns
Seven Hundred Forty-Eight Thousand Forty-Seven (748,047) shares of the Company’s
common stock, par value $0.01 per share (collectively, the “Shares”);

 

WHEREAS, Seller desires to sell up to all of his Shares in a private transaction
to third-party purchasers pursuant to one or more purchase agreements in
substantially the form attached as Exhibit A hereto (the “Purchase
Agreement(s)”);

 

WHEREAS, the Company and Seller desire to agree upon terms for the termination
of Seller’s service as a director of the Company; and

 

WHEREAS, the Company and Seller seek to resolve all issues between them,
reinforce certain continuing obligations, and amicably conclude their
relationship on the terms and condition set forth herein.

 

NOW, THEREFORE, in consideration of the foregoing recitals and the mutual
covenants and undertakings herein contained, and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, IT
IS AGREED by and among the parties hereto as follows:

 

1.         Certain Definitions.

 

(a)       “Expiration Date” means January 31, 2019.

 

(b)       “Purchase Price” means at least $1.20 per Share, inclusive of fees,
expenses and commissions associated with the transaction for which Seller is
contractually obligated.

 

(c)       “Purchasers” means such persons having executed and delivered to or at
the direction of counsel to Craig-Hallum Capital Group LLC (the “Placement
Agent”) a counterpart signature page to the Purchase Agreement and the aggregate
Purchase Price with respect to the Shares associated therewith.

 

(d)       “Transaction Documents” means this Agreement and the Purchase
Agreement(s), together with their exhibits and any other agreements contemplated
thereby in connection with the transaction contemplated hereby.

 

2.         Sale of Shares.

 

(a)       Seller agrees to sell, assign, convey, transfer and deliver all of the
Shares to the Purchasers (or such lesser amount as agreed by the Purchasers, but
no less than 6,000,000 of the Shares) at one or more closings (each, a “Closing”
and, together, the “Closings”) to take

 

--------------------------------------------------------------------------------

 

place on or before the Expiration Date at the offices of counsel to the
Placement Agent or such other place as Seller, the Company and the Purchasers
may agree. Any Shares that are not sold by Seller shall be subject to a lock-up
agreement as agreed among Seller, Company and the Placement Agent commencing on
the Effective Date and continuing through and including the later of (i) 30 days
after the effective date of a resale registration statement by the Company and
(ii) 90 days after the final Closing.

 

(b)       On or prior to the Effective Date, Seller shall deliver to counsel to
the Placement Agent (i) certificates representing all of the Shares and/or a
lost certificate affidavit in a form reasonably acceptable to the Company’s
transfer agent in respect thereof, (ii) executed stock powers endorsed in a form
reasonably acceptable to the Company’s transfer agent, with respect to all of
the Shares, and (iii) fully executed counterpart signature pages to the Purchase
Agreements.

 

(c)       On the Effective Date, the Company shall deliver to counsel to the
Placement Agent fully executed counterpart signature pages to each of the
Purchase Agreements.

 

(d)       If a Closing with respect to at least 6,000,000 shares of the
Company’s common stock held by Andrew Sealfon has not occurred on or prior to
the Expiration Date, then this Agreement shall terminate and be of no further
force and effect, except that Sections 9 (Confidentiality), 12(a) (Costs and
Expenses) and 12(g) (Governing Law) shall survive such termination.

 

(e)       For the avoidance of doubt, each of the Company and Seller intends
that, from and after the Effective Date, all conditions to Closing are and shall
be beyond their control.

 

3.         Representations and Warranties of Seller. Seller represents and
warrants to the Company (which representations and warranties shall survive the
consummation of the transactions contemplated by this Agreement):

 

(a)       The Seller has the requisite power and authority to execute and
deliver this Agreement and to consummate the transactions contemplated hereby,
and this Agreement constitutes a legal, valid and binding obligation of the
Seller enforceable against it in accordance with its terms.

 

(b)       Seller owns, of record and beneficially, the Shares free and clear of
any liens, pledges, security interest, mortgages or encumbrances or claims of
any kind and upon delivery of the applicable Purchase Price by the Purchaser
pursuant to the terms of the Purchase Agreement(s), the Purchasers will acquire
good and marketable title to the applicable Shares.

 

(c)       There are no agreements, arrangements or understandings prohibiting
the transfer of the Shares as contemplated under the Transaction Documents.

 

(d)       Seller has no actual knowledge of any third-party claims, existing or
threatened in writing, against the Company, except those that have been publicly
disclosed in the Company’s filings with the Securities and Exchange Commission.

 

4.         Representations and Warranties of the Company. The Company represents
and

 

- 2 -

--------------------------------------------------------------------------------

 

warrants to Seller (which representations and warranties shall survive the
consummation of the transactions contemplated by this Agreement):

 

(a)       The Company has the requisite corporate power and authority to execute
and deliver this Agreement and to consummate the transactions contemplated
hereby, and this Agreement constitutes a legal, valid and binding obligation of
the Company enforceable against it in accordance with its terms.

 

(b)       The execution and delivery by the Company of this Agreement, and the
performance by the Company of its obligations hereunder, have been duly and
validly authorized and approved by all necessary corporate action on the part of
the Company.

 

5.         Resignation from the Board. Seller shall have automatically, without
further action by Seller or the Company, resigned from the Company’s Board of
Directors effective immediately upon the first Closing. The parties agree such
resignation is not intended to be “because of a disagreement with the
registrant” as contemplated by Form 8-K promulgated under the Securities
Exchange Act of 1934, as amended.

 

6.         Mutual General Release. In consideration of the mutual covenants and
undertakings contained herein and for other good and valuable consideration,
effective upon the first Closing:

 

(a)       Seller, on behalf of himself and each of his past, present or future
affiliates, agents and counsel, and each of his and their respective legal
representatives, successors and assigns (each a “Seller Releasor”), irrevocably
releases, acquits, covenants not to sue and forever discharges, to the fullest
extent permitted by law, the Company and its past, present or future officers,
managers, directors, shareholders, partners, members, subsidiaries, affiliates,
employees, agents and counsel, and each of their respective legal
representatives, successors and assigns, of, from and against any liability,
obligation, claim or cause of action of any kind or nature whatsoever, whether
arising under any contract or otherwise at law or in equity, whether known or
unknown, direct or indirect, liquidated, matured, contingent or otherwise, of
any Seller Releasor, in each case, that arises from or relates to any facts,
events, circumstances or conduct arising or occurring on or before the date of
this Agreement, except any claims arising from or relating to any facts, events,
circumstances or conduct arising or occurring after the date of this Agreement.

 

(b)       Company, on behalf of itself and each of its past, present or future
officers, managers, directors, shareholders, partners, members, subsidiaries,
affiliates, employees, agents and counsel, and each of their respective legal
representatives, successors and assigns (each a “Company Releasor”), irrevocably
releases, acquits, covenants not to sue and forever discharges, to the fullest
extent permitted by law, Seller and his past, present or future affiliates,
agents and counsel, and each of their respective legal representatives,
successors and assigns (each, a “Seller Releasee”), of, from and against any
liability, obligation, claim or cause of action of any kind or nature
whatsoever, whether arising under any contract or otherwise at law or in equity,
whether known or unknown, direct or indirect, liquidated, matured, contingent or
otherwise, of any Company Releasor, in each case, that arises from or relates to
any facts, events, circumstances or conduct arising or occurring on or before
the date of this Agreement, except for (i) any claim against a Seller Releasee
arising from or relating to Seller’s acts or

 

- 3 -

--------------------------------------------------------------------------------

 

omissions that constitute intentional fraud relating to or arising from
litigation involving EMED; and (ii) any claims arising from or relating to any
facts, events, circumstances or conduct arising or occurring after the date of
this Agreement.

 

7.         Non-Disclosure and Non-Interference. Neither party to this Agreement
shall conduct himself or itself in any manner that is or would reasonably be
expected to be in each case to be materially (materiality applies to each word)
detrimental, inimical or injurious to the interests, goodwill, business, assets
or reputation of the other party. Neither party shall make statements or
representations, or otherwise communicate, directly or indirectly, in writing,
orally, or otherwise, publicly or privately, or take any action, directly or
indirectly, which could reasonably be expected to disparage or lead to unwanted
or unfavorable publicity to the other party or any of his or its affiliates or
their respective officers, directors, employees, businesses or reputations. The
restrictions of this Section 7 shall terminate six (6) months following the
consummation of the first Closing. Notwithstanding the foregoing, nothing in
this Agreement shall preclude a party from making truthful statements at any
time.

 

8.         Confidentiality.

 

(a)       Each of the Company and Seller agrees that the existence, terms and
conditions of this Agreement and the other Transaction Documents shall be
confidential information and that, without the prior written consent of the
other party, shall not be disclosed by such party to any third party (other than
his or its advisors and agents), nor shall such party permit the disclosure to
any third party of any such information, except as required by applicable law or
a final, binding and non-appealable order of a court of competent jurisdiction
(and only then if a reasonable time before making any such disclosure, the
disclosing party shall consult with the other party regarding such disclosure
and use his or its best efforts to obtain confidential treatment for such
portions of the disclosure as may be requested by the other party).

 

(b)       Notwithstanding the foregoing, (i) the Company may disclose the
existence, terms and conditions of this Agreement and the other Transaction
Documents to prospective Purchasers provided such prospects agree to maintain
its confidentiality on the same terms as the foregoing sentence, and (ii) each
of the Company and Seller may disclose the existence, terms and conditions of
this Agreement and the other Transaction Documents as, in the opinion of
counsel, is required by applicable law or regulation.

 

9.         Further Assurances. The Company and Seller each agrees to do such
things, perform such acts and make, execute, acknowledge and deliver such
documents as may be reasonably necessary and customary to complete the
transactions contemplated by this Agreement. In particular, without limitation,
each of Seller and the Company shall (i) reasonably cooperate with and make
themselves available to the Placement Agent to support its marketing efforts to
prospective Purchasers, and (ii) do such things as may be reasonably necessary
to effect the transfer of the Shares as contemplated herein.

 

10.       Miscellaneous.

 

(a)       Cost and Expenses. Each of the Company and Seller will pay their own
respective costs and expenses (including attorneys’ fees, accountants’ fees and
other professional

 

- 4 -

--------------------------------------------------------------------------------

 

fees and expenses) in connection with the negotiation, preparation, execution
and delivery of this Agreement.

 

(b)       Entire Agreement. This Agreement, together with its exhibits, contains
the entire agreement between the parties hereto with respect to the transactions
contemplated hereunder, and supersedes all negotiations, representations,
warranties, commitments, offers, contracts and writings relating to the subject
matter hereof prior to the date hereof. No waiver and no modification or
amendment of any provision of this Agreement shall be effective unless
specifically made in writing and duly signed by the party or parties to be bound
thereby.

 

(c)       Counterparts. This Agreement may be executed in one or more
counterparts and with .pdf or other electronic signatures, each of which shall
be deemed an original, but all of which, together, shall constitute one and the
same instrument.

 

(d)       Assignment. Successors and Assigns. The respective rights and
obligations of the parties hereto shall not be assignable, without the prior
written consent of the other party. This Agreement shall be binding upon and
inure to the benefit of the parties hereto and their successors and permitted
assigns.

 

(e)       Severability. In the event any provision of this Agreement or portion
thereof is found to be wholly or partially invalid, illegal or unenforceable in
any judicial proceeding, then such provision shall be deemed to be modified or
restricted to the extent and in the manner necessary to render the same valid
and enforceable, or shall be deemed excised from this Agreement, as the case may
require, and this Agreement shall be construed and enforced to the maximum
extent permitted by law, as if such provision had been originally incorporated
herein as so modified or restricted, or as if such provisions had not been
originally incorporated herein, as the case may be.

 

(f)       Headings. The captions of the various Sections of this Agreement have
been inserted only for convenience of reference and shall not be deemed to
modify, explain, enlarge or restrict any of the provisions of this Agreement.

 

(g)       Governing Law. The validity, interpretation and effect of this
Agreement shall be governed exclusively by the laws of the State of New York,
without giving effect to the provisions, policies or principles of any state law
relating to the choice or conflict of laws. All disputes, litigation,
proceedings or other legal actions by any party to this Agreement in connection
with or relating to this Agreement or any matters described or contemplated in
this Agreement shall be instituted in the courts of the State of New York or of
the United States in the State of New York. Each party to this Agreement
irrevocably submits to the exclusive jurisdiction of the courts of the State of
New York and of the United States sitting in the State of New York in connection
with any such dispute, litigation, action or proceeding arising out of or
relating to this Agreement. Each party irrevocably waives any defense or
objection it may now or hereafter have based on forum non conveniens and waives
any objection to venue of any action instituted hereunder.

 

(h)       Rights Cumulative; Waiver. The rights and remedies of the parties
hereto under this Agreement shall be cumulative and not exclusive of any rights
or remedies which either party would otherwise have hereunder or at law or in
equity or by statute, and no failure or

 

- 5 -

--------------------------------------------------------------------------------

 

delay by either party in exercising any right or remedy shall impair any such
right or remedy or operate as a waiver of such right or remedy, nor shall any
single or partial exercise of any power or right preclude such party’s other or
further exercise or the exercise of any power or right. The waiver by any party
hereto of a breach of any provision of this Agreement shall not operate or be
construed as a waiver of any preceding or succeeding breach and no failure by
either party to exercise any right or privilege hereunder shall be deemed a
waiver of such party’s rights or privileges hereunder or shall be deemed a
waiver of such party’s rights to exercise the same at any subsequent time or
times hereunder.

 

(i)        Specific Performance. Each of the parties hereto acknowledges and
agrees that in the event of any breach of this Agreement, the non-breaching
party or parties would be irreparably harmed and could not be made whole by
monetary damages. It is accordingly agreed that the parties hereto will waive
the defense in any action for specific performance that a remedy at law would be
adequate and that the parties hereto, in addition to any other remedy to which
they may be entitled at law or in equity, shall be entitled to compel specific
performance of this Agreement.

 

 

[Remainder of page intentionally left blank]

 

 

- 6 -

--------------------------------------------------------------------------------

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement Regarding
Stock Sale as of the date first written above.

 

 

Seller:

 

 

/s/ Dr. Paul Mark Baker

Dr. Paul Mark Baker

 

 

The Company:

 

Repro-Med Systems, Inc. d/b/a RMS Medical Products

 

 

By: /s/ Daniel S. Goldberger

Name: Daniel S. Goldberger

Title:   Chairman of the Board and

            interim Chief Executive Officer

 

- 7 -

--------------------------------------------------------------------------------

 

Exhibit A

 

Form of Purchase Agreement(s)

 

- 8 -

--------------------------------------------------------------------------------